MLL-R causes the aberrant expression of oncogenic MLL fusion proteins (MLL-FPs), and disease typically manifests as either acute myeloid or acute lymphoid leukemias (AML or ALL) and accounts for 10% of adult AML cases and 70–80% of infant leukemias [2]. This evidence concerns the gene KMT2A and acute myeloid leukemia.